More than a decade ago, Addyi—marketed as the “female Viagra”—was approved amid political pressure, heavy lobbying, and a lot ...

Addyi is the first and only FDA-approved, hormone-free pill clinically proven to treat low sexual desire in women RALEIGH, N.C., July 24, 2025 /PRNewswire/ -- Sprout Pharmaceuticals today announced ...

The FDA expanded its approval of Addyi, a pill to treat low libido in women, to include postmenopausal women up to age 65. The approval will open up new treatment options for older women, but experts ...

The U.S. Food and Drug Administration recently expanded approval of Addyi, a daily pill for low sex drive, to postmenopausal women up to age 65. This change could reach millions more women but faces ...

SAVANNAH, GA (WTOC) - A couple of weeks ago, the FDA decided to approve a controversial drug intended to treat women suffering from low libido. One local OB/GYN explains what exactly this means, and ...

The first prescription drug to enhance women’s sexual drive won regulatory approval on Tuesday, clinching a victory for a lobbying campaign that had accused the Food and Drug Administration of gender ...

On December 15, 2025, the U.S. FDA approved Addyi (flibanserin) for the treatment of hypoactive sexual desire disorder (HSDD) in postmenopausal women under the age of 65. Addyi was previously approved ...

On October 17, 2015, a new drug, Addyi (ADD-ee, flibanserin), becomes available to treat the 10 percent of women whose low libido, or “female hypoactive sexual desire disorder,” causes significant ...

WASHINGTON -- The Food and Drug Administration on Tuesday approved the first prescription drug designed to boost sexual desire in women, a milestone long sought by a pharmaceutical industry eager to ...

IRVINE, CA – July 5, 2023 – The Ad Firm is thrilled to announce the publication of an abstract by Sprout Pharmaceuticals, showcasing the remarkable effects of Addyi (flibanserin) on low libido among ...